Associated Papers
Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients.
Teixeira AL et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2008
Select a paper to view details